DANIEL VAENA, MD
Medical Oncology Physician · GERMANTOWN, TN
Individual Active NPI 1578548376
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 922 | 171,554 | $16,615,923 | $4,614,084 | $3,687,426 |
| 2023 | 716 | 142,601 | $12,253,180 | $3,454,676 | $2,756,558 |
| 2022 | 743 | 147,113 | $11,936,950 | $3,337,244 | $2,665,333 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 19,200 | $56 | $45 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 14,915 | $3 | $2 |
| J9299 | Injection, nivolumab, 1 mg | 12,760 | $30 | $24 |
| J9267 | Injection, paclitaxel, 1 mg | 7,759 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 7,200 | $49 | $39 |
| J0897 | Injection, denosumab, 1 mg | 6,540 | $26 | $21 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 5,500 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,122 | $0 | $0 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 2,904 | $26 | $21 |
| J1930 | Injection, lanreotide, 1 mg | 2,640 | $47 | $37 |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 2,510 | $26 | $21 |
| J9171 | Injection, docetaxel, 1 mg | 2,408 | $1 | $1 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 54546 | TN |
| Medical Oncology Physician | 207RX0202X | 35503 | IA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Tennessee
- NPI 1336147263
- NPI 1083801450
- NPI 1902420268
- NPI 1730403072
- NPI 1295778330
- NPI 1053340802
- NPI 1902838964
- NPI 1750313631
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.